Novel Histone Modification Markers Identified in Gastric Cancer

Strategic Insights -

Researchers in Liaoning, China, have identified new histone modification markers in gastric cancer (GC) cells using chromatin immunoprecipitation microarray (ChIP-chip) analysis. The study aimed to determine the potential of these markers to distinguish between normal and GC cells, as well as their correlation with DNA methylation. The research suggests that CpG island microarray coupled with ChIP (ChIP-chip) can identify novel targets of gene silencing in GC, providing a broader genomic understanding.

Key Takeaways:

  • Researchers identified 134 genes that exhibited the highest signal-to-noise ratio of H3-K9 trimethylation over acetylation in MKN45 cells.
  • ChIP-qPCR results agreed with those obtained from the ChIP-chip analysis, indicating the reliability of the method.
  • Aberrant DNA methylation status and mRNA expression levels were identified for selected genes (PSD, SMARCC1, and Vps37A) in GC cell lines.
  • ChIP-chip analysis can identify novel targets of gene silencing in GC, providing a broader genomic understanding compared to single-gene studies.
  • The study suggests that ChIP-chip is the most effective approach for assessing the genome-wide status of epigenetic regulation.
  • The research has the potential to lead to the development of new diagnostic markers and therapeutic strategies for gastric cancer.

Statistics:

  • 134 genes exhibited the highest signal-to-noise ratio of H3-K9 trimethylation over acetylation in MKN45 cells.
  • 46 genes exhibited the highest signal-to-noise ratio of H3-K9 trimethylation over H3-K4 trimethylation in MKN45 cells.
  • 5 genes (PSD, SMARCC1, Vps37A, and 2 other unidentified genes) exhibited aberrant DNA methylation status and mRNA expression levels in GC cell lines.

Sources:

  • Genome-wide analysis of histone modifications by ChIP-chip to identify silenced genes in gastric cancer. Oncology Reports, 2015;33(5):2567-2574.
  • Spandidos Publ Ltd, Pob 18179, Athens, 116 10, Greece
  • Liaoning Prov Tumor Hosp, Internal Med, Shenyang 110042, Liaoning, People's Republic of China
  • X.J. Zhu and J. Liu et al.